DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Largest single US health insurer, owned by UnitedHealth Group
UnitedHealthcare is the largest single commercial health insurer in the US, covering ~50M members through employer-sponsored plans and ACA marketplace. Generally favorable GLP-1 coverage for diabetes; weight-loss requires PA on most plans.
UHC covers Wegovy and Zepbound with prior auth on most plans — typically requires BMI ≥30 or ≥27 with comorbidity, plus 3-6 months of documented lifestyle modification. Ozempic and Mounjaro covered for diabetes at tier 2. Optum Rx (UHC PBM) tightened step-therapy requirements in 2025.
Sample copays based on a representative UnitedHealthcare plan. Your specific plan may differ.
| Product | Status | Sample copay |
|---|---|---|
| Hims & Hers Weight Loss | Not covered | — |
| Mounjaro T2D + trial of metformin first | Step therapy | $40/mo |
| Ozempic T2D diagnosis | Covered | $40/mo |
| Zepbound BMI ≥30, comorbidity, lifestyle, OR OSA + obesity (faster approval) | PA required | $55/mo |
| Wegovy BMI ≥30 or ≥27+comorbidity, 6-month documented lifestyle program | PA required | $55/mo |
Look up your specific plan ID for plan-level accuracy. Open formulary tool
Coverage shown is a sample plan and not a guarantee for your specific UnitedHealthcare plan. Always verify with member services or your benefits administrator. We update this page when formulary changes are detected — last verified May 16, 2026.
Looking for a specific medication? Browse all GLP-1 reviews →